Found 14 matching trials
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin PHASE1 The purpose of this Phase I study is to test the safety of different doses ...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up)
Learn More & Join Trial
Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies PHASE1 The Allo-RevCAR01-T-CD123 drug is a combination of a cellular component (Al...
Show More Location
Universitätsklinikum Ulm
Learn More & Join Trial
Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial) PHASE1 This study is to provide locally produced, bispecific CD19 CD20 CAR T cells...
Show More Location
University Hospital Basel, Division of Hematology or Medical Oncology
Learn More & Join Trial
Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker PHASE1 This dose-escalating phase I trial assesses for the first time the safety, ...
Show More Location
Universitätsklinikum Ulm
Learn More & Join Trial
Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma PHASE1 This is a single-arm trial that will evaluate the safety and feasibility of...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma PHASE2 This phase II trial studies how well an umbilical cord blood transplant wit...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris NA This is an investigator-initiated, single-center, single-arm, open-label ex...
Show More Location
Traditional Chinese and Western Medicine Hospital of Wuhan, Wuhan, Hubei
Learn More & Join Trial
Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies PHASE1 This dose-escalating phase I trial assesses for the first time the safety, ...
Show More Location
Universitätsklinikum Ulm
Learn More & Join Trial
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies PHASE1 This study is testing Allo-QuadCAR01-T, a new off-the-shelf CAR-T therapy f...
Show More Location
University of Chicago
Learn More & Join Trial
A Phase I Trial of Anti-GD2 T-cells (1RG-CART) PHASE1 The purpose of this first in human study is to determine the safety and fea...
Show More Location
University College London Institute of Child Health & Great Ormond Street Hospital
Learn More & Join Trial